Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

Alexander Koch, Sebastian Voigt, Carsten Kruschinski et al. · Critical Care · 2011 · 280 citations · Full text

Veterinary Medicine, Immunology, Critical Care Medicine +15

Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis

Athina Savva, Maria Raftogiannis, Fotini Baziaka et al. · Journal of Infection · 2011 · 89 citations

Medicine, Immunology, Infectious Diseases +16

Thrombogenic role of cells undergoing apoptosis

Jun Wang, Ivy Weiss, Kristen M Svoboda et al. · British Journal of Haematology · 2001 · 87 citations

Life Sciences, Oncology, Pharmacology +17

Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

Martin Mohren, Ilka Markmann, Kathleen Jentsch‐Ullrich et al. · British Journal of Cancer · 2005 · 78 citations · Full text

Medicine, Hematology, Oncology +14

VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma

J L Pittet, P de Moerloose, Guido Reber et al. · Clinical Chemistry · 1996 · 74 citations · Full text

Medicine, Diagnostic Sciences, Biopharmaceutics +12